Rejected
at 4:11 p.m. Oct, 31, 2023 ]
by
Alex
Author:
JusticeCowx12
Type of change:
Updated content
Rationale for change
Would be better as one by one
Rejection reason
no way to recall order
Current
Suggested
Text
Text
One by one
One by one
Text
Text
One by one
One by one
Extra
- Note: As of 2022, USPSTF NO LONGER recommends initiating low-dose ASA in patients with >10% 10-year CVD risk. Decision should be made on a case by case basis. They also lowered the age range from 50-59 (old) to 40-59 (new)
- They also removed the ASA for CRC prevention recommendation. Sources are split on this subject and some still recommend ASA for CRC prevention
- *USPSTF no longer has recommendations for routine lipid screening in healthy adults; see Archived - Lipid Disorders in Adults: Screening
- Screening recommendations per AMBOSS and the 2019 ACC/AHA guideline are from 20 - 75 years old
- They also removed the ASA for CRC prevention recommendation. Sources are split on this subject and some still recommend ASA for CRC prevention
- *USPSTF no longer has recommendations for routine lipid screening in healthy adults; see Archived - Lipid Disorders in Adults: Screening
- Screening recommendations per AMBOSS and the 2019 ACC/AHA guideline are from 20 - 75 years old
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Empty field
Sketchy 2
Watch Hypertension SOA
Watch Hypertension SOA
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Empty field
OME
Additional Resources
Sources:
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer
https://www.aafp.org/afp/2019/0601/p670.html
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer
https://www.aafp.org/afp/2019/0601/p670.html